Key result
Transcatheter sinus venosus defect closure with OPTIMUS XXL stents achieves 100% procedural success at 6 months.
Why the study?
Is transcatheter correction using the OPTIMUS XXL partially covered stent safe and effective in adults with superior sinus venosus defects?
Cohort (n=30)
Yes
Is transcatheter correction using the OPTIMUS XXL partially covered stent safe and effective in adults with superior sinus venosus defects?
Answers are grounded in this paper and cite their sources.
Transcatheter correction of superior sinus venosus defects using the OPTIMUS XXL partially covered stent appears safe and effective with excellent early and mid-term outcomes.
Transcatheter correction has been a new innovative treatment for superior sinus venosus defects (SVDs). A dedicated long partially covered XXL stent has been developed specifically for this procedure. Its safety and efficacy have to be investigated. This study aims to evaluate the efficacy and safety of transcatheter SVDs correction with the OTIMUS XXL® partially covered stent. A prospective, nationwide, multi-center cohort study with approval to include 60 consecutive patients started in June 2023. Preliminary early and mid-term (6 months) outcomes were collected. Results: Thirty adults were enrolled over one year in 5 centers (mean age 61 years; female, 73%; dyspnea, 90%; history of atrial arrhythmia, 43%; pulmonary hypertension, 40%; heart failure, 47%; mean indexed right ventricular end-telediastolic volume= 140mL/m² on MRI). Simulation of transcatheter SVD closure was done virtually and on 3D printed models in all cases. All procedures were successful. Pulmonary vein pathway was protected in 57% of cases. Stents of 100mm and 80mm were implanted in 67% and 33% of cases respectively, using Gemini balloons. Additional stents were implanted at the upper part in 3 patients (10%). An ostium secundum atrial septal defect was closed during the same procedure in 2 patients (6.7%). No stent embolization, pulmonary vein compression, significant residual shunt or tamponade were observed. No peri-procedural death was reported during the follow-up. In one patient, a moderate pericardial effusion was observed 7 days after the procedure and resolved spontaneously. A flat thrombus of 4x22mm was fortuitously observed upholstering the bottom part of the covered stent on the systematic computed tomography scan control at 6 months. No other stent related adverse event. Transcatheter SVDs correction using OPTIMUS XXL® covered stents is safe and effective with excellent early and mid-term outcomes.
No takes yet. Share an insight, caveat, or question.
Albenque et al. (2025) conducted a cohort in Superior sinus venosus defects (n=30). Transcatheter correction with OPTIMUS XXL partially covered stent was evaluated on Procedural success. Transcatheter correction of superior sinus venosus defects using OPTIMUS XXL covered stents achieved 100% procedural success with no peri-procedural deaths at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: